姜黄素对大鼠溃疡性结肠炎IL-23/IL-17表达的影响

被引:0
作者
农荣卯
机构
[1] 广西医科大学
关键词
姜黄素; 溃疡性结肠炎; TNBS结肠炎模型; IL-17; IL-23;
D O I
暂无
年度学位
2013
学位类型
硕士
导师
摘要
目的应用姜黄素干预TNBS诱导的大鼠溃疡性结肠炎模型,研究姜黄素对大鼠溃疡性结肠炎肠黏膜及外周血IL-17、IL-23表达的影响,以探讨姜黄素对溃疡性结肠炎抗炎作用的新机制。 方法将60只雄性SD大鼠随机分为正常对照组(A组)、模型组(B组)、姜黄素治疗组(C组)和柳氮磺吡啶治疗组(D组),每组均为15只。B、C、D组大鼠按体重分别以100mg/kg的TNBS+50%乙醇溶液0.25ml灌肠制备大鼠结肠炎模型,A组大鼠予相同剂量的0.9%氯化钠溶液及50%乙醇溶液0.25ml灌肠。造模后第2日开始,按体重C组每日予100mg/kg姜黄素溶液灌胃,D组每日予100mg/kg的SASP溶液灌胃,A、B组每日予相同剂量的0.9%氯化钠灌胃,并观察大鼠每天饮食、体重变化、大便性状及潜血情况,评价各组大鼠疾病活动指数(DAI);灌胃7天后,采集大鼠血液及结肠标本备检,观察并评价结肠黏膜损伤指数(CMDI)及组织病理学活动指数(HAI),免疫组化法测定肠黏膜组织IL-17及IL-23表达水平,ELISA法测定血清IL-17及IL-23水平。 结果与模型组相比,姜黄素组DAI评分(1.22±0.88vs2.15±0.76)、CMDI评分(2.53±1.12vs4.53±0.63)、HAI评分(4.06±1.70vs7.06±1.22)、肠黏膜IL-17(2.46±1.06vs5.86±1.92). IL-23(3.06±1.79vs5.40±1.80)及血清IL-17(1.57±0.32vs2.11±0.25)和IL-23(4.99±1.74vs7.41±0.96)表达水平均有下降,差异有统计学意义(P<0.05);姜黄素组与SASP组相比,DAI评分、CMDI评分、HAI评分、IL-17和IL-23表达水平均无明显差异性(P>0.05)。 结论姜黄素可以通过抑制IL-23及IL-17的表达,减轻TNBS诱导的大鼠溃疡性结肠炎的肠道炎症,具有抗炎作用。
引用
收藏
页数:46
共 42 条
[31]
Curcumin; a Curcuma longa constituent; acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.[J].Laura Camacho-Barquero;Isabel Villegas;Juan Manuel Sánchez-Calvo;Elena Talero;Susana Sánchez-Fidalgo;Virginia Motilva;Catalina Alarcón de la Lastra.International Immunopharmacology.2006, 3
[32]
Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial [J].
Hanai, Hiroyuki ;
Iida, Takayuki ;
Takeuchi, Ken ;
Watanabe, Fumitoshi ;
Maruyama, Yasuhiko ;
Andoh, Akira ;
Tsujikawa, Tomoyuki ;
Fujiyama, Yosihihide ;
Mitsuyama, Keiichi ;
Sata, Michio ;
Yamada, Masami ;
Iwaoka, Yasushi ;
Kanke, Kazunari ;
Hiraishi, Hideyuki ;
Hirayama, Kazuhisa ;
Arai, Hajime ;
Yoshii, Shigehito ;
Uchijima, Masato ;
Nagata, Toshi ;
Koide, Yukio .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (12) :1502-1506
[33]
Curcumin prevents the development of dextran sulfate sodium (DSS)-Induced experimental colitis [J].
Deguchi, Yasuyuki ;
Andoh, Akira ;
Inatomi, Osamu ;
Yagi, Yuhki ;
Bamba, Shigeki ;
Araki, Yoshio ;
Hata, Kazunori ;
Tsujikawa, Tomoyuki ;
Fujiyama, Yoshihide .
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (11) :2993-2998
[34]
Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution [J].
Heller, F ;
Florian, P ;
Bojarski, C ;
Richter, J ;
Christ, M ;
Hillenbrand, B ;
Mankertz, J ;
Gitter, AH ;
Bürgel, N ;
Fromm, M ;
Zeitz, M ;
Fuss, I ;
Strober, W ;
Schulzke, JD .
GASTROENTEROLOGY, 2005, 129 (02) :550-564
[35]
Characteristics of intestinal dendritic cells in inflammatory bowel diseases [J].
Hart, AL ;
Al-Hassi, HO ;
Rigby, RJ ;
Bell, SJ ;
Emmanuel, AV ;
Knight, SC ;
Kamm, MA ;
Stagg, AJ .
GASTROENTEROLOGY, 2005, 129 (01) :50-65
[36]
Curcumin therapy in inflammatory bowel disease: A pilot study [J].
Holt, PR ;
Katz, S ;
Kirshoff, R .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (11) :2191-2193
[37]
Interleukin-17 family members and inflammation [J].
Kolls, JK ;
Lindén, A .
IMMUNITY, 2004, 21 (04) :467-476
[38]
Optimizing anti-TNF treatment in inflammatory bowel disease [J].
Rutgeerts, P ;
Van Assche, G ;
Vermeire, S .
GASTROENTEROLOGY, 2004, 126 (06) :1593-1610
[39]
Curcumin inhibits mitogen stimulated lymphocyte proliferation; NF-kappa-B activation and IL-2 signaling.[J].D. Ranjan;C. Chen;T.D. Johnston;K.S. Reddy;T.T. Khan;M. Nagabhushan.Journal of Surgical Research.2003, 2
[40]
The Role of Cyclooxygenase and Lipoxygenase in Cancer Chemoprevention.[J].M. Cuendet ;;M. Pezzuto ;.Drug Metabolism and Drug Interactions.2000, 1-4